HK1101398A1 - Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2- methoxy-quinoline - Google Patents

Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2- methoxy-quinoline

Info

Publication number
HK1101398A1
HK1101398A1 HK07109303.6A HK07109303A HK1101398A1 HK 1101398 A1 HK1101398 A1 HK 1101398A1 HK 07109303 A HK07109303 A HK 07109303A HK 1101398 A1 HK1101398 A1 HK 1101398A1
Authority
HK
Hong Kong
Prior art keywords
chlorophenyl
synthesis process
quinoline
bromo
methoxy
Prior art date
Application number
HK07109303.6A
Other languages
English (en)
Inventor
Walter Ferdinand Maria Fillier
Rudy Laurent Maria Broeckx
Patrick Rene Angibaud
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1101398A1 publication Critical patent/HK1101398A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK07109303.6A 2004-05-03 2007-08-27 Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2- methoxy-quinoline HK1101398A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04076321 2004-05-03
PCT/EP2005/051932 WO2005105783A1 (en) 2004-05-03 2005-04-28 Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline

Publications (1)

Publication Number Publication Date
HK1101398A1 true HK1101398A1 (en) 2007-10-18

Family

ID=34965002

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07109303.6A HK1101398A1 (en) 2004-05-03 2007-08-27 Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2- methoxy-quinoline

Country Status (11)

Country Link
US (1) US7572916B2 (ja)
EP (1) EP1756085B1 (ja)
JP (1) JP4917022B2 (ja)
CN (1) CN100567291C (ja)
AT (1) ATE471316T1 (ja)
AU (1) AU2005238222B2 (ja)
CA (1) CA2563806C (ja)
DE (1) DE602005021878D1 (ja)
ES (1) ES2346986T3 (ja)
HK (1) HK1101398A1 (ja)
WO (1) WO2005105783A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0920927A2 (pt) 2008-11-13 2019-09-24 Link Medicine Corp derivados de azaquinolinona e usos dos mesmos
AU2016308564B2 (en) 2015-08-17 2018-04-26 Kura Oncology, Inc. Methods of treating cancer patients with farnesyl transferase inhibitors
EP3838275A1 (en) 2016-11-03 2021-06-23 Kura Oncology, Inc. Farnesyltransferase inhibitors for use in methods of treating cancer
EP3793966A1 (en) 2018-05-18 2021-03-24 Kura Oncology, Inc. Synthesis of tipifarnib

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU711142B2 (en) * 1995-12-08 1999-10-07 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibiting (imidazol-5-YL)methyl-2-quinolinone derivatives
AU2001227756A1 (en) * 2000-01-12 2001-07-24 Merck And Co., Inc. Inhibitors of prenyl-protein transferase
WO2001051126A1 (en) * 2000-01-12 2001-07-19 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
HN2000000266A (es) 2000-01-21 2001-05-21 Pfizer Prod Inc Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto.
WO2002020015A1 (en) * 2000-09-05 2002-03-14 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
ATE287882T1 (de) * 2001-03-12 2005-02-15 Janssen Pharmaceutica Nv Verfahren zur herstellung von imidazolverbindungen
WO2002079147A2 (en) * 2001-03-30 2002-10-10 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
AU2003274759A1 (en) * 2002-10-28 2004-05-13 Chugai Seiyaku Kabushiki Kaisha Benzofuran compounds having antitumor activity
WO2004076446A1 (ja) * 2003-02-27 2004-09-10 Chugai Seiyaku Kabushiki Kaisha ベンゾチオフェン誘導体
AU2005238221B2 (en) * 2004-05-03 2010-09-30 Janssen Pharmaceutica N.V. Diastereoselective addition of lithiated N-methylimidazole on sulfinimines

Also Published As

Publication number Publication date
US7572916B2 (en) 2009-08-11
WO2005105783A1 (en) 2005-11-10
AU2005238222B2 (en) 2010-10-28
CN1946710A (zh) 2007-04-11
ES2346986T3 (es) 2010-10-22
US20070293680A1 (en) 2007-12-20
CA2563806A1 (en) 2005-11-10
CA2563806C (en) 2012-11-20
CN100567291C (zh) 2009-12-09
EP1756085A1 (en) 2007-02-28
ATE471316T1 (de) 2010-07-15
JP4917022B2 (ja) 2012-04-18
DE602005021878D1 (de) 2010-07-29
JP2007536334A (ja) 2007-12-13
AU2005238222A1 (en) 2005-11-10
EP1756085B1 (en) 2010-06-16

Similar Documents

Publication Publication Date Title
TWI370121B (en) Process for the preparation of a 2-pyridylethylcarboxamide derivative
TW200800947A (en) Trisubstituted amine compound
TW200633981A (en) Process for the preparation of a 2-ethylaminopyridine derivative
TN2009000012A1 (en) Amino-piperidine derivatives as cetp inhibitors
MX2007009282A (es) Nuevos procesos para la preparacion de un 2h-cromeno.
SG166019A1 (en) Quinoline derivatives and use thereof as mycobacterial inhibitors
MX338041B (es) Inhibidores de demetilasa-1 especificos de lisina y su uso.
MY129796A (en) Novel anti-inflammatory androstane derivatives
GEP20115171B (en) Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
TW200640913A (en) 5-Substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
MX2010006063A (es) Derivados de 4-bencil-amino-pirrolidina 1,2-disustituida como inhibidores de la proteina de transferencia de colesteril-ester (cetp) utiles para el tratamiento de las enfermedades tales como hiperlipidemia o arterioesclerosis.
TW200744594A (en) Quinoline derivatives as antibacterial agents
DE602005008953D1 (de) Substituierte chinolinderivate als inhibitoren von mitotischem kinesin
WO2009121033A3 (en) Substituted nitrogen heterocycles and synthesis and uses thereof
HK1101398A1 (en) Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2- methoxy-quinoline
WO2006134499A3 (en) 2-(1h-indolylsulfanyl)-aryl amine derivatives
HK1101326A1 (en) Diastereoselective addition of lithiated n-methylimidazole on sulfinimines
WO2008059521A3 (en) Novel process for the preparation of moxifloxacin hydrochloride and a novel polymorph of moxifloxacin
MY145540A (en) Chemical process
WO2007016609A3 (en) Method for the synthesis of quinoliνe derivatives
MY148880A (en) N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression
TW200612944A (en) 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-(substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors
MX2009007868A (es) Proceso para la preparacion de monoclorhidrato de 8-hidroxi-5-[(1r)-1-hidroxi-2[[(1r)-2-(4-metoxifenil)-1-metiletil ]amino]-etil]-2(1h)-quinolinona.
WO2012168213A3 (en) Novel process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline
EA200601531A1 (ru) Моногидрохлорид 8-гидрокси-5-[(1r)-1-гидрокси-2-[[(1r)-2-(4-метоксифенил)-1-метилэтил]амино]этил]-2(1h)-хинолинона в кристаллической форме и способ его получения